BETA: Please send your feedback!
Copart
CPRT:NAS
Miscellaneous Commercial Services
$16.88bn
LARGE cap
$73.68
(-2.56%)
0.51%
since start of 2019
31.04
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2006
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Willis J. Johnson | Executive Chairman | Male |
| A. Jayson Adair | Chief Executive Officer & Director | Male |
| Marvin L. Schmidt | Founder | Male |
| Vincent W. Mitz | President & Director | Male |
| Jeffrey Liaw, MBA | Chief Financial Officer & Senior VP-Finance | Male |
| Rama Prasad, MBA | Chief Technology Officer & Senior Vice President | Male |
| Sean Eldridge | Chief Operating Officer & Senior Vice President | Male |
| Gregory R. DePasquale | Secretary, Senior Vice President & General Counsel | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 1
Sorrento Therapeutics - Competitors and Related Companies
How Sorrento Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Sorrento Therapeutics
SRNE:NAS
Biotechnology
$275.06mm
SMALL cap
$2.10
(-0.15%)
-0.27%
since start of 2019
-0.97
Loading…